scholarly journals Metastatic Breast Cancer to the Bladder – case report and review of literature

2010 ◽  
Vol 4 (5) ◽  
Author(s):  
Tomasz Pawlik ◽  
Elżbieta Łuczyńska ◽  
Anna Chwalibóg ◽  
Joanna Anioł ◽  
Janusz Ryś
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Case Report ◽  
Metastatic Breast ◽  
Review Of Literature

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature

2013 ◽  
Vol 141 (2) ◽  
pp. 167-172 ◽  
Author(s):  
Eleonora Teplinsky ◽  
Derrick Cheung ◽  
Ilan Weisberg ◽  
Ramon E. A. Jacobs ◽  
Martin Wolff ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Case Report ◽  
Hepatitis B ◽  
Metastatic Breast ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Review Of Literature ◽  
Hepatitis B Reactivation

Metastatic Breast Cancer Presenting as a Gastric Primary with Linitis Plastica: a Case Report and Review of Literature

2020 ◽  
Vol 51 (2) ◽  
pp. 698-702
Author(s):  
Abigail Go ◽  
Mudresh Mehta ◽  
Tatiana Bihun ◽  
Danielle Carpenter ◽  
Sofia Ghani
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Case Report ◽  
Metastatic Breast ◽  
Linitis Plastica ◽  
Review Of Literature

Surviving Metastatic Breast Cancer for 18 Years: A Case Report and Review of the Literature

2011 ◽  
Vol 17 (5) ◽  
pp. 521-524 ◽  
Author(s):  
Soley Bayraktar ◽  
Monica T. Garcia-Buitrago ◽  
Erin Hurley ◽  
Stefan Gluck
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Case Report ◽  
Metastatic Breast ◽  
Review Of The Literature

scholarly journals Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report

2020 ◽  
Vol 13 (1) ◽  
pp. 304-308 ◽  
Author(s):  
Alyssa Schlotman ◽  
Adam Stater ◽  
Kyle Schuler ◽  
Judd Heideman ◽  
Vandana Abramson
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Case Report ◽  
Metastatic Breast ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Hepatotoxic Effect ◽  
Er Positive ◽  
Grade 3 ◽  
Experienced Grade

A 49-year-old woman with ER-positive/PR-negative/HER2-negative metastatic breast cancer experienced Grade 3 hepatotoxicity following initiation of a clinical trial of fulvestrant, palbociclib, and erdafitinib. Fulvestrant was determined to be the drug most likely responsible for this hepatotoxic effect. This case report details the timing and nature of this drug-induced liver injury, adding support to an area that has yet to be described adequately in the existing literature.

Sign in / Sign up

Export Citation Format

Share Document